視神経症(Optic Neuropathy):世界の治験レビュー(2015年上半期版)...市場調査レポートについてご紹介

【英文タイトル】Optic Neuropathy Global Clinical Trials Review, H1, 2015

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Optic Neuropathy 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Optic Neuropathy to Ophthalmology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Optic Neuropathy to Ophthalmology Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Optic Neuropathy Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
Sigma-Tau S.p.A. 28
Clinical Trial Overview of Sigma-Tau S.p.A. 28
SBI Biotech Co., Ltd. 29
Clinical Trial Overview of SBI Biotech Co., Ltd. 29
Regenera Pharma Ltd. 30
Clinical Trial Overview of Regenera Pharma Ltd. 30
Highmark Inc. 31
Clinical Trial Overview of Highmark Inc. 31
Eli Lilly and Company 32
Clinical Trial Overview of Eli Lilly and Company 32
Bayer AG 33
Clinical Trial Overview of Bayer AG 33
Allergan, Inc. 34
Clinical Trial Overview of Allergan, Inc. 34
Clinical Trial Overview of Top Institutes / Government 35
Tehran University of Medical Sciences 35
Clinical Trial Overview of Tehran University of Medical Sciences 35
Shahid Beheshti University of Medical Sciences 36
Clinical Trial Overview of Shahid Beheshti University of Medical Sciences 36
Hong Kong Eye Hospital 37
Clinical Trial Overview of Hong Kong Eye Hospital 37
Second Military Medical University 38
Clinical Trial Overview of Second Military Medical University 38
Jikei University School of Medicine 39
Clinical Trial Overview of Jikei University School of Medicine 39
Isfahan University of Medical Sciences 40
Clinical Trial Overview of Isfahan University of Medical Sciences 40
Mount Sinai Hospital 41
Clinical Trial Overview of Mount Sinai Hospital 41
University of Colorado 42
Clinical Trial Overview of University of Colorado 42
University Hospital Tubingen 43
Clinical Trial Overview of University Hospital Tubingen 43
National Eye Institute 44
Clinical Trial Overview of National Eye Institute 44
Five Key Clinical Profiles 45
Appendix 64
Abbreviations 64
Definitions 64
Research Methodology 65
Secondary Research 65
About GlobalData 66
Contact Us 66
Disclaimer 66
Source 66


【レポート販売概要】

■ タイトル:視神経症(Optic Neuropathy):世界の治験レビュー(2015年上半期版)
■ 英文:Optic Neuropathy Global Clinical Trials Review, H1, 2015
■ 発行日:2015年1月21日
■ 調査会社:GlobalData
■ 商品コード:GDHC2527CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。